-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Mineralys Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2022 to Q2 2025.
- Mineralys Therapeutics, Inc. Return On Equity for the quarter ending June 30, 2025 was -70.4 %, a 65.3% decline year-over-year.
- Mineralys Therapeutics, Inc. annual Return On Equity for 2024 was -68 %, a 157% decline from 2023.
- Mineralys Therapeutics, Inc. annual Return On Equity for 2023 was -26.5 %, a 136% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)